Sale!

HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test

Original price was: $340.Current price is: $290.

-15%

The HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test is a cutting-edge molecular diagnostic tool that analyzes HER2 gene amplification and RNA expression levels. This comprehensive test helps identify HER2-positive cancers, particularly breast cancer, enabling targeted treatment strategies. By detecting HER2 gene amplification through DNA analysis and quantifying RNA expression, healthcare providers can determine the most effective therapeutic approaches. The test is crucial for patients with suspected or confirmed breast cancer, guiding treatment decisions with monoclonal antibodies like trastuzumab. At just $290 USD, this advanced genetic analysis provides valuable insights for personalized cancer care and improved treatment outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test

Comprehensive Introduction to HER2 Neu Testing

The HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test represents a significant advancement in molecular oncology diagnostics. This sophisticated test evaluates the HER2 (Human Epidermal Growth Factor Receptor 2) gene, which plays a critical role in cell growth and division. When the HER2 gene becomes amplified or overexpressed, it can drive aggressive cancer growth, particularly in breast cancer cases. Understanding HER2 status is essential for developing targeted treatment strategies that can significantly improve patient outcomes.

What This Test Measures and Detects

Our comprehensive HER2 Neu test provides detailed analysis through multiple detection methods:

  • DNA Detection: Identifies HER2 gene amplification through precise molecular analysis
  • Quantification Analysis: Measures the exact level of HER2 gene copies present
  • RNA Detection: Evaluates HER2 RNA expression levels for complete assessment
  • Qualitative Assessment: Determines HER2 status as positive or negative

Who Should Consider This Test

This advanced diagnostic test is recommended for individuals experiencing specific clinical scenarios:

  • Patients with newly diagnosed breast cancer requiring HER2 status determination
  • Individuals with metastatic breast cancer needing treatment guidance
  • Patients considering targeted therapy with HER2-directed medications
  • Those with ambiguous or borderline HER2 results from previous testing
  • Individuals with family history of HER2-positive cancers
  • Patients requiring monitoring of treatment response to HER2-targeted therapies

Key Benefits of HER2 Neu Testing

Undergoing HER2 Neu DNA Detection & Quantification RNA Detection offers numerous advantages:

  • Personalized Treatment Planning: Enables selection of targeted therapies like trastuzumab
  • Improved Prognostic Accuracy: Provides clearer understanding of cancer aggressiveness
  • Enhanced Treatment Efficacy: Helps avoid ineffective treatments and associated side effects
  • Comprehensive Assessment: Combines DNA and RNA analysis for complete HER2 profiling
  • Early Intervention Guidance: Supports timely implementation of appropriate therapies
  • Cost-Effective Care: Reduces unnecessary treatment expenses through precise targeting

Understanding Your Test Results

Our HER2 Neu test results provide clear, actionable information:

  • HER2 Positive: Indicates gene amplification and potential benefit from HER2-targeted therapies
  • HER2 Negative: Suggests standard treatment approaches may be more appropriate
  • Quantitative Data: Provides specific gene copy numbers for precise assessment
  • RNA Expression Levels: Offers additional confirmation of HER2 status
  • Clinical Correlation: Results should be interpreted alongside other diagnostic findings

Test Pricing and Availability

Test Name Regular Price Discount Price
HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test $340 USD $290 USD

Nationwide Testing Availability

GGC DNA maintains comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Book Your Test Today

Take control of your health journey with our advanced HER2 Neu DNA Detection & Quantification RNA Detection Qualitative Test. Our experienced genetic counselors and oncology specialists are available to discuss your results and provide comprehensive guidance. Contact us today to schedule your test and receive the personalized care you deserve.

Call or WhatsApp: +1(267) 388-9828

Important Pre-Test Information

Before your appointment, please ensure you:

  • Complete and sign the required consent documentation
  • Bring any relevant clinical history and previous test results
  • Follow any specific preparation instructions provided by our staff
  • Arrive at your scheduled appointment time with proper identification

Turnaround Time and Results Delivery

We understand the importance of timely results in cancer diagnosis and treatment planning. Our standard turnaround time is:

  • Email Results: 36 hours after sample processing
  • Phone Consultation: Available within 24 hours for urgent cases
  • Complete Report: Delivered within 3 working days

Trust GGC DNA for accurate, reliable HER2 Neu testing that empowers you and your healthcare team to make informed treatment decisions. Our commitment to excellence in genetic diagnostics ensures you receive the highest quality care and support throughout your testing journey.